Company Statement: Valeant Pharmaceuticals to acquire Obagi Medical
MLex Summary: NYSE-listed pharmaceutical company Valeant Pharmaceuticals to acquire Nasdaq-listed specialty pharmaceutical company Obagi Medical Products.Statement follows in full....To view the full article, register now.
Already a subscriber? Click here to view full article